Prednicortone vet 20 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

prednicortone vet 20 mg

dechra regulatory b.v. - prednisolon - tablett - 20 mg

Prednicortone vet 5 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

prednicortone vet 5 mg

dechra regulatory b.v. - prednisolon - tablett - 5 mg

Hedylon 25 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

hedylon 25 mg

livisto int’l, s.l. - prednisolon - tablett - 25 mg

Hedylon 5 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

hedylon 5 mg

livisto int’l, s.l. - prednisolon - tablett - 5 mg

Medrol 4 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

medrol 4 mg

pfizer as - metylprednisolon - tablett - 4 mg

Medrol 16 mg ノルウェー - ノルウェー語 - Statens legemiddelverk

medrol 16 mg

pfizer as - metylprednisolon - tablett - 16 mg

Canaural vet ノルウェー - ノルウェー語 - Statens legemiddelverk

canaural vet

dechra veterinary products - dietanolaminfusidat / framycetinsulfat / nystatin / prednisolon - Øredråper, suspensjon - 5 mg / 5 mg / 100000 ie / 2.5 mg

Abiraterone Accord 欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetat - prostata neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka 欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abirateronacetat - prostata neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Abiraterone Mylan 欧州連合 - ノルウェー語 - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateronacetat - prostata neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.